Title: BILLAS PASSED BY THE HOUSE H.209
Official Title: BILLAS PASSED BY THE HOUSE H.209
Number of Sections: 3
Source: versions - As Passed By the House (Official)
Media Type: application/pdf
Strikethrough Detection: 11 sections found

================================================================================

Section 1:
2025 Page 1 of 11
1 H.209
2 Introduced by Representative Goldman of Rockingham
3 Referred to Committee on
4 Date:
5 Subject: Health; education; intranasal epinephrine; prescribing and dispensing
6 authority; schools
7 Statement of purpose of bill as introduced: This bill proposes to allow a health
8 care professional to prescribe and issue standing orders for the use of
9 intranasal epinephrine in schools. It proposes to allow a school to maintain a
10 stock supply of intranasal epinephrine. The bill further proposes to allow a
11 school administrator to authorize school nurses or other designated personnel
12 to administer or have a student self-administer intranasal epinephrine in
13 accordance with a student’s plan of action for managing the student’s life-
14 threatening allergy.
15 An act relating to intranasal epinephrine in schools
16 It is hereby enacted by the General Assembly of the State of Vermont:
17 Sec. 1. 16 V.S.A. § 1388 is amended to read:
18 § 1388. STOCK SUPPLY AND EMERGENCY ADMINISTRATION OF
19 EPINEPHRINE AUTO-INJECTORS
BILLAS PASSED BY THE HOUSE H.209
2025 Page 2 of 11
1 (a) As used in this section:
2 (1) “Designated personnel” means a school employee, agent, or
3 volunteer who has been authorized by the school administrator to provide and
4 administer epinephrine auto-injectors and intranasal epinephrine under this
5 section and who has completed the training required by State Board policy.
6 (2) “Epinephrine auto-injector” means a single-use device that delivers a
7 premeasured dose of epinephrine.
8 (3) “Health care professional” means a physician licensed pursuant to 26
9 V.S.A. chapter 23 or 33, an advanced practice registered nurse licensed to
10 prescribe drugs and medical devices pursuant to 26 V.S.A. chapter 28, or a
11 physician assistant licensed to prescribe drugs and medical devices pursuant to
12 26 V.S.A. chapter 31.
13 (4) “Intranasal epinephrine” means a nasal spray delivering a dose a
14 epinephrine.
15 (5) “School” means a public or approved independent school and
16 extends to school grounds, school-sponsored activities, school-provided
17 transportation, and school-related programs.
18 (5)(6) “School administrator” means a school’s principal or headmaster.
19 (b)(1) A health care professional may prescribe an epinephrine auto-
20 injector or intranasal epinephrine, or both, in a school’s name, which may be
21 maintained by the school for use as described in subsection (d) of this section.
BILLAS PASSED BY THE HOUSE H.209
2025 Page 3 of 11
1 The health care professional shall issue to the school a standing order for the
2 use of an epinephrine auto-injector prescribed under this section, including
3 protocols for:
4 (A) assessing whether an individual is experiencing a potentially life-
5 threatening allergic reaction;
6 (B) administering an epinephrine auto-injector and intranasal
7 epinephrine to an individual experiencing a potentially life-threatening allergic
8 reaction;
9 (C) caring for an individual after administering an epinephrine auto-
10 injector to him or her or intranasal epinephrine, including contacting
11 emergency services personnel and documenting the incident; and
12 (D) disposing of used or expired epinephrine auto-injectors and
13 intranasal epinephrine.
14 (2) A pharmacist licensed pursuant to 26 V.S.A. chapter 36 or a health
15 care professional may dispense prescribed epinephrine auto-injectors
16 prescribed or intranasal epinephrine, or both, to a school.
17 (c) A school may maintain a stock supply of epinephrine auto-injectors or
18 intranasal epinephrine, or both. A school may enter into arrangements with
19 epinephrine auto-injector manufacturers or suppliers of epinephrine auto-
20 injectors or intranasal epinephrine, or both, to acquire epinephrine auto-
21 injectors these products for free or at reduced or fair market prices.
BILLAS PASSED BY THE HOUSE H.209
2025 Page 4 of 11
1 (d) The school administrator may authorize a school nurse or designated
2 personnel, or both, to:
3 (1) provide an epinephrine auto-injector or intranasal epinephrine to a
4 student for self-administration according to a plan of action for managing the
5 student’s life-threatening allergy maintained in the student’s school health
6 records pursuant to section 1387 of this title;
7 (2) administer a prescribed epinephrine auto-injector or intranasal
8 epinephrine to a student according to a plan of action maintained in the
9 student’s school health records; and
10 (3) administer an epinephrine auto-injector or intranasal epinephrine, in
11 accordance with the protocol issued under subsection (b) of this section, to a
12 student or other individual at a school if the nurse or designated personnel
13 believe in good faith that the student or individual is experiencing anaphylaxis,
14 regardless of whether the student or individual has a prescription for an
15 epinephrine auto-injector or intranasal epinephrine.
16 (e) Designated personnel, a school, and a health care professional
17 prescribing an epinephrine auto-injector or intranasal epinephrine, or both, to a
18 school shall be immune from any civil or criminal liability arising from the
19 administration or self-administration of an epinephrine auto-injector or
20 intranasal epinephrine under this section, unless the person’s conduct
21 constituted intentional misconduct. Providing or administering an epinephrine
BILLAS PASSED BY THE HOUSE H.209
2025 Page 5 of 11
1 auto-injector or intranasal epinephrine under this section does not constitute
2 the practice of medicine.
3 (f) On or before January 1, 2014, the The State Board, in consultation with
4 the Department of Health, shall adopt policies for managing students with life-
5 threatening allergies and other individuals with life-threatening allergies who
6 may be present at a school. The policies shall:
7 (1) establish protocols to prevent exposure to allergens in schools;
8 (2) establish procedures for responding to life-threatening allergic
9 reactions in schools, including postemergency procedures;
10 (3) implement a process for schools and the parents or guardians of
11 students with a life-threatening allergy to jointly develop a written
12 individualized allergy management plan of action that:
13 (A) incorporates instructions from a student’s physician regarding
14 the student’s life-threatening allergy and prescribed treatment;
15 (B) includes the requirements of section 1387 of this title, if a student
16 is authorized to possess and self-administer emergency medication at school;
17 (C) becomes part of the student’s health records maintained by the
18 school; and
19 (D) is updated each school year;
20 (4) require education and training for school nurses and designated
21 personnel, including training related to storing and administering an
BILLAS PASSED BY THE HOUSE H.209
2025 Page 6 of 11
1 epinephrine auto-injector or intranasal epinephrine and recognizing and
2 responding to a life-threatening allergic reaction; and
3 (5) require each school to make publicly available protocols and
4 procedures developed in accordance with the policies adopted by the State
5 Board under this section.
6 Sec. 2. EFFECTIVE DATE
7 This act shall take effect on July 1, 2025.
Sec. 1. 16 V.S.A. § 1388 is amended to read:

Section 2:
§ 1388. STOCK SUPPLY AND EMERGENCY ADMINISTRATION OF
EPINEPHRINE AUTO-INJECTORS
(a) As used in this section:
(1) “Designated personnel” means a school employee, agent, or
volunteer, or practical nurse licensed pursuant to 26 V.S.A. chapter 28 who
has been authorized by the school administrator nurse to provide and
administer epinephrine auto-injectors and intranasal epinephrine under this

Section 3:
section and who has completed the training required by State Board policy.
(2) “Epinephrine auto-injector” means a single-use device that delivers
a premeasured dose of epinephrine.
(3) “Health care professional” means a physician licensed pursuant to
26 V.S.A. chapter 23 or 33, an advanced practice registered nurse licensed to
prescribe drugs and medical devices pursuant to 26 V.S.A. chapter 28, or a
BILLAS PASSED BY THE HOUSE H.209
2025 Page 7 of 11
physician assistant licensed to prescribe drugs and medical devices pursuant to
26 V.S.A. chapter 31.
(4) “Intranasal epinephrine” means a nasal spray delivering a dose of
epinephrine.
(5) “School” means a public or approved independent school and
extends to school grounds, school-sponsored activities, school-provided
transportation, and school-related programs.
(5)(6) “School administrator” means a school’s principal or
headmaster.
(7) “School nurse” means a school nurse endorsed by the Agency of
Education pursuant to the Licensing of Educators and the Preparation of
Educational Professionals rule (CVR 22-000-010).
(b)(1) A health care professional may prescribe an epinephrine auto-
injector or intranasal epinephrine, or both, in a school’s name, which may be
maintained by the school for use as described in subsection (d) of this section.
The health care professional, in consultation with the school nurse, shall issue
to the school a standing order for the use of an epinephrine auto-injector
prescribed under this section, including protocols for:
(A) assessing whether an individual is experiencing a potentially life-
threatening allergic reaction;
BILLAS PASSED BY THE HOUSE H.209
2025 Page 8 of 11
(B) administering an epinephrine auto-injector and intranasal
epinephrine to an individual experiencing a potentially life-threatening
allergic reaction;
(C) caring for an individual after administering an epinephrine auto-
injector to him or her or intranasal epinephrine, including contacting
emergency services personnel and documenting the incident; and
(D) disposing of used or expired epinephrine auto-injectors and
intranasal epinephrine.
(2) A pharmacist licensed pursuant to 26 V.S.A. chapter 36 or a health
care professional may dispense prescribed epinephrine auto-injectors
prescribed or intranasal epinephrine, or both, to a school.
(c) A school may maintain a stock supply of epinephrine auto-injectors or
intranasal epinephrine, or both. A school may enter into arrangements with
epinephrine auto-injector manufacturers or suppliers of epinephrine auto-
injectors or intranasal epinephrine, or both, to acquire epinephrine auto-
injectors these products for free or at reduced or fair market prices.
(d) The school administrator may authorize a school nurse or, who in turn
may authorize designated personnel, or both, to:
(1) provide an epinephrine auto-injector or intranasal epinephrine to a
student for self-administration according to a plan of action for managing the
BILLAS PASSED BY THE HOUSE H.209
2025 Page 9 of 11
student’s life-threatening allergy maintained in the student’s school health
records pursuant to section 1387 of this title;
(2) administer a prescribed epinephrine auto-injector or intranasal
epinephrine to a student according to a plan of action maintained in the
student’s school health records; and
(3) administer an epinephrine auto-injector or intranasal epinephrine,
in accordance with the protocol issued under subsection (b) of this section, to a
student or other individual at a school if the nurse or designated personnel
believe in good faith that the student or individual is experiencing anaphylaxis,
regardless of whether the student or individual has a prescription for an
epinephrine auto-injector or intranasal epinephrine.
(e) Designated personnel, a school, and a health care professional
prescribing an epinephrine auto-injector or intranasal epinephrine, or both, to
a school shall be immune from any civil or criminal liability arising from the
administration or self-administration of an epinephrine auto-injector or
intranasal epinephrine under this section, unless the person’s conduct
constituted intentional misconduct. Providing or administering an epinephrine
auto-injector or intranasal epinephrine under this section does not constitute
the practice of medicine.
(f) On or before January 1, 2014, the The State Board, in consultation with
the Department of Health, shall adopt policies for managing students with life-
BILLAS PASSED BY THE HOUSE H.209
2025 Page 10 of 11
threatening allergies and other individuals with life-threatening allergies who
may be present at a school. The policies shall:
(1) establish protocols to prevent exposure to allergens in schools;
(2) establish procedures for responding to life-threatening allergic
reactions in schools, including postemergency procedures;
(3) implement a process for schools school nurses and the parents or
guardians of students with a life-threatening allergy to jointly develop a
written individualized allergy management plan of action that:
(A) incorporates instructions from a student’s physician health care
professional regarding the student’s life-threatening allergy and prescribed
treatment;
(B) includes the requirements of section 1387 of this title, if a student
is authorized to possess and self-administer emergency medication at school;
(C) becomes part of the student’s health records maintained by the
school; and
(D) is updated each school year;
(4) require education and training for school nurses and designated
personnel, including training related to storing and administering an
epinephrine auto-injector or intranasal epinephrine and recognizing and
responding to a life-threatening allergic reaction; and
BILLAS PASSED BY THE HOUSE H.209
2025 Page 11 of 11
(5) require each school to make publicly available protocols and
procedures developed in accordance with the policies adopted by the State
Board under this section.
Sec. 2. EFFECTIVE DATE
This act shall take effect on July 1, 2025.
[DELETED: LASPDBYTEHEH5Pe1of1HIdbyReGnofRRdtoCeoDS:H;e;ile;pgadda;sStofpeofblasi:Tsblpstoawahcepltopeadiesgosfrteueoileeins.Itpstoawasltomn0sksyofile.Teblfrpstoaw1slartoaeslnsororddp2toarorheastsrileei3aewhasspnofanfrmgtessl4tga5Anatrgtoileeins6ItishyedbyteGlAyofteSeofV7S.1.16V.§8isadtor8§1.SKSYADEYANO9EEA]
[DELETED: LASPDBYTEHEH5Pe2of1()Asudintss()“dp”msasle,a,ovrwohsbnadbyteslartopeaareeasadileeurtsnadwohscdtetgrdbySeBdp()“ea”msasedettdspddeofe()“hcep”msapnldptto2V.cr23or3,anadperdneldt0pedsadmldsptto26V.cr2,or1pnatldtopedsadmldsptt226V.cr33()“le”msanlsydgade4e5()“”msapcoraditsla6estoslg,sda,s7t,adsdp8()“la”msassplorh9()Ahhceplmypeaneea0irorile,orb,inassn,whmyb1mdbyteslfrueasddinsn()oftss]
[DELETED: LASPDBYTEHEH5Pe3of1Tehhceplslietoteslasgorfrtueofaneearpdurtss,ipsf()agwranilisegapyltgacr()aganeearadieetoanilegapylgar()cgfranilaraganeea0irtohmorhrorile,igc1eysspladdgtei;a2()dgofudoredeeasa3ile4()Aptldptto26V.cr36orah5ceplmydepdeea6pdorile,orb,toas7()Aslmymnasksyofeeaso8ile,orb.Aslmyerioasw9eearmsorssofeea0isorile,orb,toaeeea1istepsfrfeoratrdorfrmtp]
[DELETED: LASPDBYTEHEH5Pe4of1()Teslarmyaeaslneordp,orb,t()peaneearorileetostfrsnagtoapnofanfrmgtsslgaymdintessslhrspttosn17oftst()arapdeearorieetoastagtoapnofanmdintssslhhr;a0()araneearorile,i1aewhteplidursn()oftss,to2stororilataslifteneorddp3beingdfhtttestorilisega4rsofwrtestorilhsapnfra5eearorile6()Ddp,as,adahhcep7pganeearorile,orb,to8slslbeiefmayclorcllyagfmt9anorsnofaneearo0ileeurtss,ustepsc1cdilm.Pgoragane]
[DELETED: LASPDBYTEHEH5Pe5of1arorileeurtssndsntctepeofm()OnorbeJy1,2,teTeSeB,incnwteDtofH,slatpsfrmgsswhltgasadoriswhlgaswmybeptatas.Tepss()ehpstopteetoasins()ehpsfrrgtolgarsins,igpyp0()itapsfrssadtepsorgso1sswhalgaytojydpaw2idaymtpnofant3()isisfmasspnr4tesslgayadpdt5()istersofsn17oftst,ifas6isadtopsadsreymnats7()bsptoftesshhrsmdbyt8s;a9()isudehsly0()reenadtgfrslnsadd1p,igtgrdtosgadaga]
[DELETED: LASPDBYTEHEH5Pe6of1eearorileeadrgargtoalgacr;a()reehsltomepyaepsapsddinaewhtepsadbyteSBdurtssS.2.EEDTsatslteetonJy1,2.1.16V.§8isadtor1.SKSYADEYANOEA)Asudintss)“dp”msasle,a,o,orplneldptto26V.cr28wsbnadbyteslarnetopeareeasadileeurtnadwohscdtetgrdbySeBdp)“ea”msasedettdpddeofe)“hcep”msapnldptt6V.cr23or3,anadperdneldtedsadmldsptto26V.cr2,or]
[DELETED: LASPDBYTEHEH5Pe7of1natldtopedsadmldsptt6V.cr3)“le”msanlsydgadeo)“”msapcoraditslastoslg,sda,s,adsdp)“la”msassplo)“ln”msaslneedbyteAyonpttoteLgofEsadtePnolPsre(R2)Ahhceplmypeaneearorile,orb,inassn,whmybdbyteslfrueasddinsn()oftssehhcep,incnwhtesln,slioteslasgorfrteueofaneeadurtss,igpsf)agwranilisegapylgacr]
[DELETED: LASPDBYTEHEH5Pe8of1)aganeearadietoanilegapylcr)cgfranilaraganeeartohmorhrorile,igcysspladdgtei;a)dgofudoredeeasale)Aptldptto26V.cr36oraheplmydepdeeadorile,orb,toas)Aslmymnasksyofeeasole,orb.Aslmyerioaswearmsorssofeeasorile,orb,toaeeeastepsfrfeoratrdorfrmtp)Teslarmyaeaslneo,wointyaeddp,orb,t)peaneearorileetotfrsnagtoapnofanfrmgt]
[DELETED: LASPDBYTEHEH5Pe9of1slgaymdintessslhspttosn17oftst)arapdeearorietoastagtoapnofanmdintsslhhr;a)araneearorilenaewhteplidursn()oftss,totororilataslifteneorddpeingdfhtttestorilisegasofwrtestorilhsapnfraearorile)Ddp,as,adahhcepganeearorile,orb,tslslbeiefmayclorcllyagfmtnorsnofaneearoleeurtss,ustepscdilm.Pgoraganerorileeurtssndsntcepeofm)OnorbeJy1,2,teTeSeB,incnweDtofH,slatpsfrmgsswhl]
[DELETED: LASPDBYTEHEH5Pe10of1gasadoriswhlgaswybeptatas.Tepss)ehpstopteetoasins)ehpsfrrgtolgasins,igpyp)itapsfrssslnsadtepsosofsswhalgaytojydpnidaymtpnofant)isisfmasspnhhclrgtesslgayadp)istersofsn17oftst,ifassadtopsadsreymnats)bsptoftesshhrsmdbyt;a)isudehsly)reenadtgfrslnsadd,igtgrdtosgadagaearorileeadrgagtoalgacr;a]
[DELETED: LASPDBYTEHEH5Pe11of1)reehsltomepyaepsasddinaewhtepsadbyteSdurtss.2.EEDsatslteetonJy1,2]


================================================================================

Raw Text:
BILLAS PASSED BY THE HOUSE H.209
2025 Page 1 of 11
1 H.209
2 Introduced by Representative Goldman of Rockingham
3 Referred to Committee on
4 Date:
5 Subject: Health; education; intranasal epinephrine; prescribing and dispensing
6 authority; schools
7 Statement of purpose of bill as introduced: This bill proposes to allow a health
8 care professional to prescribe and issue standing orders for the use of
9 intranasal epinephrine in schools. It proposes to allow a school to maintain a
10 stock supply of intranasal epinephrine. The bill further proposes to allow a
11 school administrator to authorize school nurses or other designated personnel
12 to administer or have a student self-administer intranasal epinephrine in
13 accordance with a student’s plan of action for managing the student’s life-
14 threatening allergy.
15 An act relating to intranasal epinephrine in schools
16 It is hereby enacted by the General Assembly of the State of Vermont:
17 Sec. 1. 16 V.S.A. § 1388 is amended to read:
18 § 1388. STOCK SUPPLY AND EMERGENCY ADMINISTRATION OF
19 EPINEPHRINE AUTO-INJECTORS

BILLAS PASSED BY THE HOUSE H.209
2025 Page 2 of 11
1 (a) As used in this section:
2 (1) “Designated personnel” means a school employee, agent, or
3 volunteer who has been authorized by the school administrator to provide and
4 administer epinephrine auto-injectors and intranasal epinephrine under this
5 section and who has completed the training required by State Board policy.
6 (2) “Epinephrine auto-injector” means a single-use device that delivers a
7 premeasured dose of epinephrine.
8 (3) “Health care professional” means a physician licensed pursuant to 26
9 V.S.A. chapter 23 or 33, an advanced practice registered nurse licensed to
10 prescribe drugs and medical devices pursuant to 26 V.S.A. chapter 28, or a
11 physician assistant licensed to prescribe drugs and medical devices pursuant to
12 26 V.S.A. chapter 31.
13 (4) “Intranasal epinephrine” means a nasal spray delivering a dose a
14 epinephrine.
15 (5) “School” means a public or approved independent school and
16 extends to school grounds, school-sponsored activities, school-provided
17 transportation, and school-related programs.
18 (5)(6) “School administrator” means a school’s principal or headmaster.
19 (b)(1) A health care professional may prescribe an epinephrine auto-
20 injector or intranasal epinephrine, or both, in a school’s name, which may be
21 maintained by the school for use as described in subsection (d) of this section.

BILLAS PASSED BY THE HOUSE H.209
2025 Page 3 of 11
1 The health care professional shall issue to the school a standing order for the
2 use of an epinephrine auto-injector prescribed under this section, including
3 protocols for:
4 (A) assessing whether an individual is experiencing a potentially life-
5 threatening allergic reaction;
6 (B) administering an epinephrine auto-injector and intranasal
7 epinephrine to an individual experiencing a potentially life-threatening allergic
8 reaction;
9 (C) caring for an individual after administering an epinephrine auto-
10 injector to him or her or intranasal epinephrine, including contacting
11 emergency services personnel and documenting the incident; and
12 (D) disposing of used or expired epinephrine auto-injectors and
13 intranasal epinephrine.
14 (2) A pharmacist licensed pursuant to 26 V.S.A. chapter 36 or a health
15 care professional may dispense prescribed epinephrine auto-injectors
16 prescribed or intranasal epinephrine, or both, to a school.
17 (c) A school may maintain a stock supply of epinephrine auto-injectors or
18 intranasal epinephrine, or both. A school may enter into arrangements with
19 epinephrine auto-injector manufacturers or suppliers of epinephrine auto-
20 injectors or intranasal epinephrine, or both, to acquire epinephrine auto-
21 injectors these products for free or at reduced or fair market prices.

BILLAS PASSED BY THE HOUSE H.209
2025 Page 4 of 11
1 (d) The school administrator may authorize a school nurse or designated
2 personnel, or both, to:
3 (1) provide an epinephrine auto-injector or intranasal epinephrine to a
4 student for self-administration according to a plan of action for managing the
5 student’s life-threatening allergy maintained in the student’s school health
6 records pursuant to section 1387 of this title;
7 (2) administer a prescribed epinephrine auto-injector or intranasal
8 epinephrine to a student according to a plan of action maintained in the
9 student’s school health records; and
10 (3) administer an epinephrine auto-injector or intranasal epinephrine, in
11 accordance with the protocol issued under subsection (b) of this section, to a
12 student or other individual at a school if the nurse or designated personnel
13 believe in good faith that the student or individual is experiencing anaphylaxis,
14 regardless of whether the student or individual has a prescription for an
15 epinephrine auto-injector or intranasal epinephrine.
16 (e) Designated personnel, a school, and a health care professional
17 prescribing an epinephrine auto-injector or intranasal epinephrine, or both, to a
18 school shall be immune from any civil or criminal liability arising from the
19 administration or self-administration of an epinephrine auto-injector or
20 intranasal epinephrine under this section, unless the person’s conduct
21 constituted intentional misconduct. Providing or administering an epinephrine

BILLAS PASSED BY THE HOUSE H.209
2025 Page 5 of 11
1 auto-injector or intranasal epinephrine under this section does not constitute
2 the practice of medicine.
3 (f) On or before January 1, 2014, the The State Board, in consultation with
4 the Department of Health, shall adopt policies for managing students with life-
5 threatening allergies and other individuals with life-threatening allergies who
6 may be present at a school. The policies shall:
7 (1) establish protocols to prevent exposure to allergens in schools;
8 (2) establish procedures for responding to life-threatening allergic
9 reactions in schools, including postemergency procedures;
10 (3) implement a process for schools and the parents or guardians of
11 students with a life-threatening allergy to jointly develop a written
12 individualized allergy management plan of action that:
13 (A) incorporates instructions from a student’s physician regarding
14 the student’s life-threatening allergy and prescribed treatment;
15 (B) includes the requirements of section 1387 of this title, if a student
16 is authorized to possess and self-administer emergency medication at school;
17 (C) becomes part of the student’s health records maintained by the
18 school; and
19 (D) is updated each school year;
20 (4) require education and training for school nurses and designated
21 personnel, including training related to storing and administering an

BILLAS PASSED BY THE HOUSE H.209
2025 Page 6 of 11
1 epinephrine auto-injector or intranasal epinephrine and recognizing and
2 responding to a life-threatening allergic reaction; and
3 (5) require each school to make publicly available protocols and
4 procedures developed in accordance with the policies adopted by the State
5 Board under this section.
6 Sec. 2. EFFECTIVE DATE
7 This act shall take effect on July 1, 2025.
Sec. 1. 16 V.S.A. § 1388 is amended to read:
§ 1388. STOCK SUPPLY AND EMERGENCY ADMINISTRATION OF
EPINEPHRINE AUTO-INJECTORS
(a) As used in this section:
(1) “Designated personnel” means a school employee, agent, or
volunteer, or practical nurse licensed pursuant to 26 V.S.A. chapter 28 who
has been authorized by the school administrator nurse to provide and
administer epinephrine auto-injectors and intranasal epinephrine under this
section and who has completed the training required by State Board policy.
(2) “Epinephrine auto-injector” means a single-use device that delivers
a premeasured dose of epinephrine.
(3) “Health care professional” means a physician licensed pursuant to
26 V.S.A. chapter 23 or 33, an advanced practice registered nurse licensed to
prescribe drugs and medical devices pursuant to 26 V.S.A. chapter 28, or a

BILLAS PASSED BY THE HOUSE H.209
2025 Page 7 of 11
physician assistant licensed to prescribe drugs and medical devices pursuant to
26 V.S.A. chapter 31.
(4) “Intranasal epinephrine” means a nasal spray delivering a dose of
epinephrine.
(5) “School” means a public or approved independent school and
extends to school grounds, school-sponsored activities, school-provided
transportation, and school-related programs.
(5)(6) “School administrator” means a school’s principal or
headmaster.
(7) “School nurse” means a school nurse endorsed by the Agency of
Education pursuant to the Licensing of Educators and the Preparation of
Educational Professionals rule (CVR 22-000-010).
(b)(1) A health care professional may prescribe an epinephrine auto-
injector or intranasal epinephrine, or both, in a school’s name, which may be
maintained by the school for use as described in subsection (d) of this section.
The health care professional, in consultation with the school nurse, shall issue
to the school a standing order for the use of an epinephrine auto-injector
prescribed under this section, including protocols for:
(A) assessing whether an individual is experiencing a potentially life-
threatening allergic reaction;

BILLAS PASSED BY THE HOUSE H.209
2025 Page 8 of 11
(B) administering an epinephrine auto-injector and intranasal
epinephrine to an individual experiencing a potentially life-threatening
allergic reaction;
(C) caring for an individual after administering an epinephrine auto-
injector to him or her or intranasal epinephrine, including contacting
emergency services personnel and documenting the incident; and
(D) disposing of used or expired epinephrine auto-injectors and
intranasal epinephrine.
(2) A pharmacist licensed pursuant to 26 V.S.A. chapter 36 or a health
care professional may dispense prescribed epinephrine auto-injectors
prescribed or intranasal epinephrine, or both, to a school.
(c) A school may maintain a stock supply of epinephrine auto-injectors or
intranasal epinephrine, or both. A school may enter into arrangements with
epinephrine auto-injector manufacturers or suppliers of epinephrine auto-
injectors or intranasal epinephrine, or both, to acquire epinephrine auto-
injectors these products for free or at reduced or fair market prices.
(d) The school administrator may authorize a school nurse or, who in turn
may authorize designated personnel, or both, to:
(1) provide an epinephrine auto-injector or intranasal epinephrine to a
student for self-administration according to a plan of action for managing the

BILLAS PASSED BY THE HOUSE H.209
2025 Page 9 of 11
student’s life-threatening allergy maintained in the student’s school health
records pursuant to section 1387 of this title;
(2) administer a prescribed epinephrine auto-injector or intranasal
epinephrine to a student according to a plan of action maintained in the
student’s school health records; and
(3) administer an epinephrine auto-injector or intranasal epinephrine,
in accordance with the protocol issued under subsection (b) of this section, to a
student or other individual at a school if the nurse or designated personnel
believe in good faith that the student or individual is experiencing anaphylaxis,
regardless of whether the student or individual has a prescription for an
epinephrine auto-injector or intranasal epinephrine.
(e) Designated personnel, a school, and a health care professional
prescribing an epinephrine auto-injector or intranasal epinephrine, or both, to
a school shall be immune from any civil or criminal liability arising from the
administration or self-administration of an epinephrine auto-injector or
intranasal epinephrine under this section, unless the person’s conduct
constituted intentional misconduct. Providing or administering an epinephrine
auto-injector or intranasal epinephrine under this section does not constitute
the practice of medicine.
(f) On or before January 1, 2014, the The State Board, in consultation with
the Department of Health, shall adopt policies for managing students with life-

BILLAS PASSED BY THE HOUSE H.209
2025 Page 10 of 11
threatening allergies and other individuals with life-threatening allergies who
may be present at a school. The policies shall:
(1) establish protocols to prevent exposure to allergens in schools;
(2) establish procedures for responding to life-threatening allergic
reactions in schools, including postemergency procedures;
(3) implement a process for schools school nurses and the parents or
guardians of students with a life-threatening allergy to jointly develop a
written individualized allergy management plan of action that:
(A) incorporates instructions from a student’s physician health care
professional regarding the student’s life-threatening allergy and prescribed
treatment;
(B) includes the requirements of section 1387 of this title, if a student
is authorized to possess and self-administer emergency medication at school;
(C) becomes part of the student’s health records maintained by the
school; and
(D) is updated each school year;
(4) require education and training for school nurses and designated
personnel, including training related to storing and administering an
epinephrine auto-injector or intranasal epinephrine and recognizing and
responding to a life-threatening allergic reaction; and

BILLAS PASSED BY THE HOUSE H.209
2025 Page 11 of 11
(5) require each school to make publicly available protocols and
procedures developed in accordance with the policies adopted by the State
Board under this section.
Sec. 2. EFFECTIVE DATE
This act shall take effect on July 1, 2025.

[DELETED: LASPDBYTEHEH5Pe1of1HIdbyReGnofRRdtoCeoDS:H;e;ile;pgadda;sStofpeofblasi:Tsblpstoawahcepltopeadiesgosfrteueoileeins.Itpstoawasltomn0sksyofile.Teblfrpstoaw1slartoaeslnsororddp2toarorheastsrileei3aewhasspnofanfrmgtessl4tga5Anatrgtoileeins6ItishyedbyteGlAyofteSeofV7S.1.16V.§8isadtor8§1.SKSYADEYANO9EEA]
[DELETED: LASPDBYTEHEH5Pe2of1()Asudintss()“dp”msasle,a,ovrwohsbnadbyteslartopeaareeasadileeurtsnadwohscdtetgrdbySeBdp()“ea”msasedettdspddeofe()“hcep”msapnldptto2V.cr23or3,anadperdneldt0pedsadmldsptto26V.cr2,or1pnatldtopedsadmldsptt226V.cr33()“le”msanlsydgade4e5()“”msapcoraditsla6estoslg,sda,s7t,adsdp8()“la”msassplorh9()Ahhceplmypeaneea0irorile,orb,inassn,whmyb1mdbyteslfrueasddinsn()oftss]
[DELETED: LASPDBYTEHEH5Pe3of1Tehhceplslietoteslasgorfrtueofaneearpdurtss,ipsf()agwranilisegapyltgacr()aganeearadieetoanilegapylgar()cgfranilaraganeea0irtohmorhrorile,igc1eysspladdgtei;a2()dgofudoredeeasa3ile4()Aptldptto26V.cr36orah5ceplmydepdeea6pdorile,orb,toas7()Aslmymnasksyofeeaso8ile,orb.Aslmyerioasw9eearmsorssofeea0isorile,orb,toaeeea1istepsfrfeoratrdorfrmtp]
[DELETED: LASPDBYTEHEH5Pe4of1()Teslarmyaeaslneordp,orb,t()peaneearorileetostfrsnagtoapnofanfrmgtsslgaymdintessslhrspttosn17oftst()arapdeearorieetoastagtoapnofanmdintssslhhr;a0()araneearorile,i1aewhteplidursn()oftss,to2stororilataslifteneorddp3beingdfhtttestorilisega4rsofwrtestorilhsapnfra5eearorile6()Ddp,as,adahhcep7pganeearorile,orb,to8slslbeiefmayclorcllyagfmt9anorsnofaneearo0ileeurtss,ustepsc1cdilm.Pgoragane]
[DELETED: LASPDBYTEHEH5Pe5of1arorileeurtssndsntctepeofm()OnorbeJy1,2,teTeSeB,incnwteDtofH,slatpsfrmgsswhltgasadoriswhlgaswmybeptatas.Tepss()ehpstopteetoasins()ehpsfrrgtolgarsins,igpyp0()itapsfrssadtepsorgso1sswhalgaytojydpaw2idaymtpnofant3()isisfmasspnr4tesslgayadpdt5()istersofsn17oftst,ifas6isadtopsadsreymnats7()bsptoftesshhrsmdbyt8s;a9()isudehsly0()reenadtgfrslnsadd1p,igtgrdtosgadaga]
[DELETED: LASPDBYTEHEH5Pe6of1eearorileeadrgargtoalgacr;a()reehsltomepyaepsapsddinaewhtepsadbyteSBdurtssS.2.EEDTsatslteetonJy1,2.1.16V.§8isadtor1.SKSYADEYANOEA)Asudintss)“dp”msasle,a,o,orplneldptto26V.cr28wsbnadbyteslarnetopeareeasadileeurtnadwohscdtetgrdbySeBdp)“ea”msasedettdpddeofe)“hcep”msapnldptt6V.cr23or3,anadperdneldtedsadmldsptto26V.cr2,or]
[DELETED: LASPDBYTEHEH5Pe7of1natldtopedsadmldsptt6V.cr3)“le”msanlsydgadeo)“”msapcoraditslastoslg,sda,s,adsdp)“la”msassplo)“ln”msaslneedbyteAyonpttoteLgofEsadtePnolPsre(R2)Ahhceplmypeaneearorile,orb,inassn,whmybdbyteslfrueasddinsn()oftssehhcep,incnwhtesln,slioteslasgorfrteueofaneeadurtss,igpsf)agwranilisegapylgacr]
[DELETED: LASPDBYTEHEH5Pe8of1)aganeearadietoanilegapylcr)cgfranilaraganeeartohmorhrorile,igcysspladdgtei;a)dgofudoredeeasale)Aptldptto26V.cr36oraheplmydepdeeadorile,orb,toas)Aslmymnasksyofeeasole,orb.Aslmyerioaswearmsorssofeeasorile,orb,toaeeeastepsfrfeoratrdorfrmtp)Teslarmyaeaslneo,wointyaeddp,orb,t)peaneearorileetotfrsnagtoapnofanfrmgt]
[DELETED: LASPDBYTEHEH5Pe9of1slgaymdintessslhspttosn17oftst)arapdeearorietoastagtoapnofanmdintsslhhr;a)araneearorilenaewhteplidursn()oftss,totororilataslifteneorddpeingdfhtttestorilisegasofwrtestorilhsapnfraearorile)Ddp,as,adahhcepganeearorile,orb,tslslbeiefmayclorcllyagfmtnorsnofaneearoleeurtss,ustepscdilm.Pgoraganerorileeurtssndsntcepeofm)OnorbeJy1,2,teTeSeB,incnweDtofH,slatpsfrmgsswhl]
[DELETED: LASPDBYTEHEH5Pe10of1gasadoriswhlgaswybeptatas.Tepss)ehpstopteetoasins)ehpsfrrgtolgasins,igpyp)itapsfrssslnsadtepsosofsswhalgaytojydpnidaymtpnofant)isisfmasspnhhclrgtesslgayadp)istersofsn17oftst,ifassadtopsadsreymnats)bsptoftesshhrsmdbyt;a)isudehsly)reenadtgfrslnsadd,igtgrdtosgadagaearorileeadrgagtoalgacr;a]
[DELETED: LASPDBYTEHEH5Pe11of1)reehsltomepyaepsasddinaewhtepsadbyteSdurtss.2.EEDsatslteetonJy1,2]